Skip to main content

Science and Technology

November 15, 2012

WASHINGTON, D.C. – Congressman Steve Cohen (D-TN-09) today announced that the U.S. Department of Health and Human Services has awarded a grant worth $71,052 to St. Jude Children’s Research Hospital. These new funds will be used to bolster the Children’s Hospitals Graduate Medical Education (CHGME) Payment Program at St. Jude. This program helps enable St.

April 26, 2012

WASHINGTON, D.C. – Congressman Steve Cohen (TN-09) today announced that the National Cancer Institute (NCI) has awarded a grant worth $302,203 to the University of Tennessee Health Science Center for cancer treatment research. Specifically, the grant will go toward the study of cancer-fighting strategies targeting the Autotaxin-LPA Receptor Axis, which has been linked to cell proliferation and migration in cancerous tumors.

April 3, 2012

MEMPHIS, TN – Congressman Steve Cohen (D-TN-9) today announced that the U.S. Department of Health and Human Services has awarded two grants totaling $724,542 to the University of Tennessee Health Science Center. A grant worth $374,792 will be used for research into the metabolism and function of vitamin D in the cornea, distributed by the National Eye Institute.

February 15, 2012

WASHINGTON, D.C. – Congressman Steve Cohen (D-TN-9) today announced the U.S. Department of Health and Human Services has awarded St. Jude Children’s Research Hospital $4,314,800 for a childhood cancer survivor study. The new federal funds will be distributed by the National Cancer Institute (NCI).

January 31, 2012

WASHINGTON, D.C. – Congressman Steve Cohen (D-TN-9) today announced the U.S. Department of Health and Human Services has awarded St. Jude Children’s Research Hospital $218,750 for Allergy, Immunology and Transplantation Research – particularly, metabolic control of regulatory T cell differentiation. The funds will be administered by the National Institute of Allergy and Infectious Diseases (NIAID).

January 20, 2012

WASHINGTON, D.C. – Congressman Steve Cohen (D-TN) today issued the following statement on House Judiciary Chairman Lamar Smith’s (R-TX) decision to postpone consideration of the Stop Online Piracy Act (H.R. 3261) – legislation that would require Internet Service Providers to block access to certain foreign websites.

December 15, 2011

Washington, D.C. – Today, Congressmen Brian Bilbray (R-CA) and Steve Cohen (D-TN) introduced H.R. 3664, the Solar Energy Regulatory Relief Act of 2011. This bipartisan legislation will promote standardization for local permitting requirements for solar energy and lower the installation costs for solar energy systems. Please see the below statements:

December 5, 2011

WASHINGTON, D.C.-- Congressman Steve Cohen (D-TN-9) today announced that the U.S. Department of Health and Human Services has awarded the University of Tennessee Health Science Center (UTHSC) a federal grant worth $399,162 for heart and vascular diseases research – specifically, to elucidate basic molecular mechanisms that lead to vascular disease in response to vascular injury and atherosclerosis. The new federal funds will be administered by the National, Heart, Lung and Blood Institute (NHLBI).

November 30, 2011

WASHINGTON, D.C. -- Congressman Steve Cohen (D-TN-9) today announced that the U.S. Department of Health and Human Services has awarded St. Jude Children’s Research Hospital a federal grant worth $262,500 for research to develop treatments for heart and vascular diseases. The new federal funding will be distributed by the National Heart, Lung and Blood Institute (NHLBI).

November 14, 2011

WASHINGTON, D.C. -- Congressman Steve Cohen (D-TN-9) today announced that the U.S. Department of Health and Human Services has awarded the University of Tennessee Health Science Center a federal grant worth $315,000 to develop a safe and effective vaccine to prevent Group A Streptococcal (GAS) infections and their complications. GAS infections include acute rheumatic fever (ARF), rheumatic heart disease (RHD) and invasive disease. The funds will be administered by the National Institute of Allergy and Infectious Diseases (NIAID).